HOW MIGHT YOU DEFY IMAGINATION?

If you feel like you’re part of something bigger, it’s because you are. At Amgen our shared mission—to serve patients—drives all that we do. It is key to our becoming one of the world’s leading biotechnology companies. We are global collaborators who achieve together—researching, manufacturing and delivering ever-better products that reach over 10 million patients worldwide. It’s time for a career you can be proud of. Join us.

QUALIFICATIONS:

• Degree Educated.
• Expirience in clinical research, evidence generation, and cross-functional collaboration.
• Understanding of Public Health, Health Equity, and Clinical Research.
• Ability to engage with internal and external stakeholders effectively.
• Strong project management and change management skills.
• Strategic agility and ability to translate brand strategy into evidence generation.
• Demonstrated ability to influence and lead teams without direct authority.
• Passion for diversity, inclusion, and equity.

WHAT YOU WILL DO

In this vital role, the IETL is a key member of the Access & Use Evidence Generation (AUEG) platform team, responsible for driving execution in the creation and management of AUEG Plans (AUEGPs) for assigned assets or programs. This role requires close collaboration with Regional Medical Heads and cross-functional asset teams to align evidence strategies with business needs.

KEY RESPONSIBILITIES:

• Lead AUEG Governance preparation for asset prioritization processes.
• Develop integrated evidence questions from regional/local evidence gaps and provide training on AUEGP generation.
• Facilitate discussions, negotiate decisions, and influence without authority across asset teams.
• Oversee AUEGP creation, management, and updates in collaboration with GMAL and Medical, Clinical, HEOR, GV&A, and Marketing Leads.
• Monitor AUEGP execution, ensuring alignment with budget and strategic objectives.
• Provide performance metrics and process improvement recommendations to the central AUEG team.
• Engage with internal and external stakeholders to optimize evidence generation.